Iradimed anticipates $25M-$26.5M Q4 revenue as 3870 pump output targets 50%+ sequential growth
What it means
- What to watch: There is a hard number in this story (50%) — the interesting part is how it compares with the last few like it.
- How the stock is trading: $IRMD -10.21% in the latest session.
- Timing: It landed during trading hours — the market got to read it live, so the session move beside it may already carry the reaction.
Where the stock stands
$IRMD last traded at $76.99, -10.21% on the session. That puts it 29% shy of its 52-week high of $107.90 and 0.8% clear of its low of $76.38 — within a tenth of its 52-week low. Over the year it has ranged 41% from low to high: a moderate band — lively, not wild. These are latest-session quotes, not live prices — the live tape is on the $IRMD page.
How much coverage it is getting
Nothing else on $IRMD in the last 30 days: this is the only story Wook has filed, so there is no run to measure it against yet. 12 related stories from the same name or desk are listed beside this one.
The bigger picture
With earnings, the number matters less than the number versus expectations — and guidance often matters more than both. A beat paired with a soft outlook can still get a cold reception. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it watches. The scanner equivalent of a quiet night shift.
Coming up
$IRMD earnings today. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the hard numbers get the last word soon.
What to watch next
For the receipts, the $IRMD page has the full chart, the filings and the valuation model these figures come from. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. And Wook AI, up top, will happily do the math — how far $IRMD sits from its high, or how this week's coverage stacks up.
How this analysis was made
Seeking Alpha published it, and Wook filed it under Earnings. It reads bullish at medium severity because of “growth” in the wording, with nothing on the bearish side to offset it. It was matched to $IRMD. It carried $25 million, $26.5 million and 50%, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on October 30, 2026. $IRMD has moved -2.76% ($79.18 to $76.99). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.